Gut Check is a periodic look at health claims made by studies, newsmakers, or conventional wisdom. We ask: Should you believe this? The claim: Women with a breast abnormality called ductal carcinoma ...

Patients with ductal carcinoma in situ (DCIS) are often treated with radiation after lumpectomy, although it has remained unclear whether this can reduce the risk of dying from this noninvasive form ...

BOSTON — A retrospective study involving 4000 patients with ductal carcinoma in situ (DCIS) has demonstrated that a radiation boost after breast-conserving surgery plus whole-breast radiation therapy ...

The Oncotype DX DCIS Score short form (DCIS Score) estimates the risk of an ipsilateral breast event (IBE) in patients with ductal carcinoma in situ (DCIS) treated with breast-conserving surgery ...

A team of researchers just discovered a set of risk factors that could help patients with ductal carcinoma in situ (DCIS) evaluate the potential benefits of radiation after breast-conserving surgery.

Adjuvant radiation therapy (RT) for good-risk ductal carcinoma in situ (DCIS) reduced long-term ipsilateral breast recurrence (IBR) by more than 50% compared with observation, results of a large ...

Soon after her diagnosis, Storm’s physician team ordered PreludeDx’s DCISionRT®, the only risk assessment test that predicts radiation therapy (RT) benefit in DCIS patients, to be run on her tumor ...

Ductal carcinoma in-situ (DCIS) accounts for one-fifth of breast cancer cases in the United States, according to the American Cancer Society. Given that it is a non-invasive form of breast cancer, ...

BOSTON--A study by researchers at Dana-Farber Cancer Institute and Brigham and Women's Hospital has found that women who chose not to receive radiation therapy following surgery for Ductal Carcinoma ...

Patients with low-risk ductal carcinoma in situ (DCIS) are unlikely to experience disease recurrence following breast conservation surgery, but radiation therapy can reduce that small risk even ...

Please provide your email address to receive an email when new articles are posted on . A radiation boost improved local control and reduced local tumor recurrence among patients with ductal carcinoma ...

LAGUNA HILLS, Calif., Feb. 12, 2025 /PRNewswire/ — Prelude Corporation (PreludeDx®), a leader in precision diagnostics for early-stage breast cancer, today announced a partnership with Hannah Storm, ...